These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 28222506)

  • 1. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
    Baazaoui N; Flory M; Iqbal K
    J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
    Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
    Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
    Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
    J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Lysosomes in a Broad Disease-Modifying Approach Evaluated across Transgenic Mouse Models of Alzheimer's Disease and Parkinson's Disease and Models of Mild Cognitive Impairment.
    Hwang J; Estick CM; Ikonne US; Butler D; Pait MC; Elliott LH; Ruiz S; Smith K; Rentschler KM; Mundell C; Almeida MF; Stumbling Bear N; Locklear JP; Abumohsen Y; Ivey CM; Farizatto KLG; Bahr BA
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31505809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rhein-Huprine Derivatives Reduce Cognitive Impairment, Synaptic Failure and Amyloid Pathology in AβPPswe/PS-1 Mice of Different Ages.
    Serrano FG; Tapia-Rojas C; Carvajal FJ; Cisternas P; Viayna E; Sola I; Munoz-Torrero D; Inestrosa NC
    Curr Alzheimer Res; 2016; 13(9):1017-29. PubMed ID: 26502813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
    Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-stage reduction of the dendritic complexity in basolateral amygdala of a transgenic mouse model of Alzheimer's disease.
    Guo C; Long B; Hu Y; Yuan J; Gong H; Li X
    Biochem Biophys Res Commun; 2017 May; 486(3):679-685. PubMed ID: 28336433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-in-life neuroanatomical and behavioural trajectories in a triple transgenic model of Alzheimer's disease.
    Kong V; Devenyi GA; Gallino D; Ayranci G; Germann J; Rollins C; Chakravarty MM
    Brain Struct Funct; 2018 Sep; 223(7):3365-3382. PubMed ID: 29948190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
    Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
    Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer's disease.
    Sri S; Pegasiou CM; Cave CA; Hough K; Wood N; Gomez-Nicola D; Deinhardt K; Bannerman D; Perry VH; Vargas-Caballero M
    Acta Neuropathol Commun; 2019 Feb; 7(1):25. PubMed ID: 30795807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitigation of synaptic and memory impairments via F-actin stabilization in Alzheimer's disease.
    P A H; Basavaraju N; Chandran M; Jaleel A; Bennett DA; Kommaddi RP
    Alzheimers Res Ther; 2024 Sep; 16(1):200. PubMed ID: 39244567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
    Baazaoui N; Iqbal K
    J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease.
    Ciavardelli D; Silvestri E; Del Viscovo A; Bomba M; De Gregorio D; Moreno M; Di Ilio C; Goglia F; Canzoniero LM; Sensi SL
    Cell Death Dis; 2010 Oct; 1(10):e90. PubMed ID: 21368863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.